A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers

NCT07226843 · clinicaltrials.gov ↗

PHASE1

Phase

RECRUITING

Status

460

Enrollment

INDUSTRY

Sponsor class

Conditions

Lymphoma, Non-Hodgkin's
Lymphoma, Diffuse Large B-Cell
Follicular Lymphoma

Interventions

DRUG: LY4584180
DRUG: Rituximab

Sponsor

Eli Lilly and Company